-

OpenEvidence Integrates ASCO Guidelines, Figures and Flowcharts into Specialty Oncology Model

MIAMI--(BUSINESS WIRE)--Today, OpenEvidence, the most widely used medical knowledge platform, announced an integration of ASCO Guidelines, figures, and flowcharts into the OpenEvidence model.

“ASCO is committed to helping clinicians access our Guidelines and the evidence behind them." --Clifford A. Hudis, MD, FACP, FASCO

Share

As a part of OpenEvidence's commitment to creating advanced AI models for medical specialties, the company has extended their oncology model to include the ASCO Guidelines. ASCO Guidelines will now appear within OpenEvidence answers, accompanied by peer-reviewed evidence, precise citations, and a direct link to the ASCO website.

“ASCO is committed to helping clinicians access our Guidelines and the evidence behind them," said Clifford A. Hudis, MD, FACP, FASCO, Chief Executive Officer of ASCO. "Our license agreement with OpenEvidence makes it easier for their users to find information to help determine the next best steps in a patient's care.” The OpenEvidence team incorporated the ASCO Guidelines within its oncology model and conducted a thorough evaluation to ensure the system accurately reflects the original evidence. All responses include direct links to ASCO's source documents, allowing users to view the full guidance alongside the broader body of clinical evidence available on the OpenEvidence platform throughout the United States.

"As an oncologist, I recognize the complexity of clinical decision making as the number of treatment options multiply. Expert guidance and recommendations through algorithms and decision trees are natural for clinicians to read and interpret, but represent a challenge for language models. I’ve been excited to work directly on this project to train models to incorporate the ASCO Guidelines, figures, and flowcharts into the broader medical literature and make them more accessible to our users," said Travis Zack, MD PhD, Chief Medical Officer of OpenEvidence."

About OpenEvidence

OpenEvidence is the most widely used medical AI platform among U.S. physicians, and is trusted by hundreds of thousands of verified clinicians to make high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence was founded with the mission to organize and expand the world's collective medical knowledge. Learn more at openevidence.com.

Contacts

OpenEvidence

Details
Headquarters: Miami, FL
CEO: Daniel Nadler
Employees: na
Organization: PRI

Release Versions

Contacts

Social Media Profiles
More News From OpenEvidence

American Medical Society for Sports Medicine and OpenEvidence Announce Partnership to Bring AI-Powered Sports Medicine Resources to Clinicians and Patients

MIAMI & LEAWOOD, Kan.--(BUSINESS WIRE)--The American Medical Society for Sports Medicine (AMSSM) and OpenEvidence today announced a partnership that will focus on co-developing AI-powered educational resources on sports medicine for both patients and clinicians. This exclusive collaboration brings the expertise of AMSSM’s sports medicine physicians to OpenEvidence, the leading AI-powered clinical decision support platform, and will build on the AMSSM’s robust foundation of educational materials....

OneOncology and OpenEvidence Partner to Improve Cancer Care Nationwide

MIAMI & NASHVILLE, Tenn.--(BUSINESS WIRE)--OpenEvidence, the most widely used AI-powered medical search and clinical decision-support platform, and OneOncology, a physician-led national platform empowering independent medical specialty practices, today announced a partnership to embed OpenEvidence into certain clinical applications used across OneOncology’s platform to enable physicians to use OpenEvidence for clinical evidence retrieval, reference and research. The integration is designed to m...

Springer Nature and OpenEvidence Announce Agreement to Maximise Exposure of Trusted Findings On OpenEvidence Platform

NEW YORK & MIAMI--(BUSINESS WIRE)--Springer Nature and OpenEvidence today announced a subscription agreement that brings peer-reviewed content from Springer Nature into OpenEvidence, where physicians can retrieve and cite it during patient care. This agreement took effect August 4 and forms part of Springer Nature’s community led ARC3 framework. Clinicians and healthcare professionals need quick and easy access to the very latest trusted insights to help inform their decisions. Today's announce...
Back to Newsroom